For older people and frail people, the long-term benefit of medicines reduces and the potential for harm from adverse effects increases. When the benefit–risk balance changes in this way, medicine review and optimisation are important to simplify the therapeutic regimen, reduce inappropriate medicines and minimise risks. In this article, pharmacist prescriber Linda Bryant uses two case studies to illustrate important considerations during medicine reviews
Rare disorders
Wednesday 27 October 2021, 12:45 AM

With the number of recognised rare disorders at more than 8000 and rising, their combined prevalence makes them uncommonly common. In people with these disorders, supportive, long-term, consistent and accessible contact with primary care is central and essential. This article provides a heuristic framework for the care and management of a person with a rare disorder and their whānau
This article was written by Rosemary Marks, Stephen Robertson and Anna Latu
This continuing medical education activity has been endorsed by the RNZCGP and has been approved for up to 1 CME credit for continuing professional de, Educate small, BACK panel - grey
Kia ora and welcome to New Zealand Doctor Rata Aotearoa
Not a subscriber? Unlock this article by subscribing here.